Table 1 Patient characteristics.
From: Predictive factors of prognosis after radiation and steroid pulse therapy in thyroid eye disease
All cases (N = 77) | ||
|---|---|---|
Age (years) | Median | 58 |
Range | (25–80) | |
Male:female | 29:48 | |
Duration of ophthalmopathy (months) | Median | 7.3 |
Range | 1.1–43.2 | |
Thyroid function at radiotherapy | Hyperthyroid | 13 |
Euthyroid | 56 | |
Hypothyroid | 8 | |
Previous treatment for hyperthyroidism | Anti-thyroid agent | 66 |
Radioactive iodine | 2 | |
Surgery | 7 | |
None | 9 | |
Previous treatment for ophthalmopathy | Local corticosteroids | 4 |
Systemic corticosteroids | 33 | |
Surgery | 6 | |
None | 43 | |
Number of smokers | 24 | |
Number of DM | 3 | |
Total dose of mPSL (mg) | Median | 5625 |
Range | (2250–9000) | |
CAS at radiotherapy | 2–3 | 37 |
4–5 | 30 | |
6–7 | 10 | |
TSAb (%) | Median | 1282.4 |
Range | (166.0–8045.0) | |
SD of signal intensity in the ROI | Median | 113.5 |
Range | (25.9–268.2) | |
Follow-up time (months) | Median | 25.0 |
Range | (6.2–106.1) | |
